🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and chemists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Several experts said the demand for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Material Removal

Based on the social media company, the platform has taken down violative material and prohibited associated keywords and query recommendations. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, glowing testimonials and detailed instructions for mixing or administering at residence.

After moments of joining one group, a seller posted WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Information and Pricing

Within these groups, messages display dark colored parcels with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram stated it actively monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has already seen individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to potentially serious health risks”.